Company record · VBIO
Valion Bio, Inc.
Valion Bio, Inc. disclosed a change in its chief financial officer, effective December 11, 2026. Until then the filing lists Lisa Wolf in the role. See the filing record.
The record holds 1 verified CFO change for Valion Bio, Inc. from Form 8-K filings, filed November 5, 2026.
The CFO seat
Computed from the records below: a move filed on or after the 10-K replaces the 10-K's signature.
| Status | Change pending |
|---|---|
| Officer | Lisa Wolf |
| Effective | December 11, 2026 |
| Basis | Latest move: departure, 8-K filed November 5, 2026 |
Seat timeline
1Every verified record for this seat, newest first, dated as the filing states it.
2026-11-05Departure
Valion Bio, Inc. discloses CFO departure: Lisa Wolfeffective December 11, 2026 · 8-K filed November 5, 2026 · sec.gov, Item 5.02
Company
| Ticker | VBIO |
|---|---|
| SEC CIK | 0001787740 |
| Industry (SIC) | Not established: the company is not on the roster |
This record covers what the tracked filings state; it is not a complete history of the company's finance leadership. Spot an error? Send a correction.